Emerging therapeutics and evolving assessment criteria for intracranial metastases in patients with oncogene-driven non-small-cell lung cancer
K Pan, K Concannon, J Li, J Zhang… - Nature Reviews …, 2023 - nature.com
The improved survival outcomes of patients with non-small-cell lung cancer (NSCLC),
largely owing to the improved control of systemic disease provided by immune-checkpoint …
largely owing to the improved control of systemic disease provided by immune-checkpoint …